SRC and cancer: It has been reported that, when activated, SRC promotes tumorigenesis through its downstream signaling pathways, including PI3 kinase/Akt/mTOR and MEK/ERK, to facilitate cancer growth, migration, invasion, and metastasis, as well as chemotherapy resistance13–15.